THERAPEUTIC CLASS

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

---

Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), in patients with diabetes mellitus. Furthermore, COVID-19 might also predispose infected
individuals to hyperglycaemia. Interacting with other risk factors, hyperglycaemia might modulate immune and inflammatory responses, thus predisposing patients to severe COVID-19 and possible lethal outcomes

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Endocrine & Metabolic system

Specific Detail Info

https://doi.org/10.1038/s41574-020-00435-4

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment